Millennium Management
NRXP icon

Millennium Management’s NRX Pharmaceuticals NRXP Stock Holding History

Millennium Management’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,624
Closed -$60.8K – 6237
2024
Q4 		$60.8K Buy
+27,624
New +$37.1K ﹤0.01% 5563
2023
Q4 		– Sell
-15,718
Closed -$40.9K – 6382
2023
Q3 		$40.9K Buy
+15,718
New +$52.3K ﹤0.01% 5522
2022
Q3 		– Sell
-29,682
Closed -$178K – 7359
2022
Q2 		$178K Buy
+29,682
New +$390K ﹤0.01% 5691
2022
Q1 		– Sell
-1,326
Closed -$63K – 7299
2021
Q4 		$63K Buy
+1,326
New +$95.7K ﹤0.01% 6414

Other funds holding NRXP

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return

Millennium Management's NRXP Position: Q1 2025 in Review

Millennium Management sold out of NRX Pharmaceuticals (NRXP) in Q1 2025, closing a stake of 27,624 shares — an estimated $60.8K sold.

Millennium Management first reported a position in NRXP in Q4 2021 and held it in 4 quarters. The position peaked at $178K in Q2 2022. 22 funds tracked by Wall St. Rank hold NRXP as of Q1 2025.

  • Millennium Management reported no remaining NRX Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 27,624 NRX Pharmaceuticals shares in Q1 2025, an estimated $60.8K.
  • Millennium Management first reported a position in NRX Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Millennium Management's NRX Pharmaceuticals position peaked at $178K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.